Jazz Pharmaceuticals plc — Director's Dealing 2020

Jan 7, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2020-01-03

Reporting Person: Swisher Daniel N JR (President and COO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-01-03	Ordinary Shares	D	1599	$146.09	Disposed	29126	Direct

Footnotes

F1: Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.

F2: Includes 140 ordinary shares and 73 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on May 31, 2019 and November 29, 2019, respectively.